The inclusion of real world evidence in clinical development planning

The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials

(2017) Gemma L. Clayton et al.   Trials

A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs

(2017) Mikkel Ankarfeldt et al.   Clinical Epidemiology

The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization

(2016) Clementine Nordon et al.   VALUE IN HEALTH

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices

(2015) B Woods et al.   HEART

Get real in individual participant data (IPD) meta-analysis: a review of the methodology

(2015) Thomas P. A. Debray et al.   Research Synthesis Methods

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

A Bayesian Mixed-Treatment Comparison Meta-analysis of Treatments for Alcohol Dependence and Implications for Planning Future Trials

(2014) Stacia M. DeSantis et al.   MEDICAL DECISION MAKING

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

(2014) Jordi Río et al.   Multiple Sclerosis Journal

The analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regression

(2014) R. Martina et al.   PHARMACEUTICAL STATISTICS

Meta-analysis of randomized phase II trials to inform subsequent phase III decisions

(2014) Danielle L Burke et al.   Trials

A Comparison of National Guidelines for Network Meta-Analysis

(2014) Andrew Laws et al.   VALUE IN HEALTH

Planning future studies based on the conditional power of a meta-analysis

(2012) Verena Roloff et al.   STATISTICS IN MEDICINE

Adaptive trial designs: a review of barriers and opportunities

(2012) John A Kairalla et al.   Trials

Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study

(2011) R. Lanzillo et al.   ACTA NEUROLOGICA SCANDINAVICA

Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis

(2011) Rachel Halpern et al.   ADVANCES IN THERAPY

Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study

(2011) X Montalban et al.   Multiple Sclerosis Journal

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evidence synthesis as the key to more coherent and efficient research

(2009) Alexander J Sutton et al.   BMC Medical Research Methodology

Bias modelling in evidence synthesis

(2008) Rebecca M. Turner et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY